Dai-ichi Life Holdings’s Quest Diagnostics DGX Stock Holding History

Dai-ichi Life Holdings’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,716	Closed	-$230K	–	127
2016 Q3	$230K	Hold	2,716	–	–	0.01%	524
2016 Q2	$221K	Buy	+2,716	New	+$207K	0.01%	497
2015 Q4	–	Sell	-3,897	Closed	-$240K	–	554
2015 Q3	$240K	Hold	3,897	–	–	0.01%	515
2015 Q2	$283K	Hold	3,897	–	–	0.01%	503
2015 Q1	$299K	Hold	3,897	–	–	0.01%	514
2014 Q4	$261K	Hold	3,897	–	–	0.01%	530
2014 Q3	$236K	Hold	3,897	–	–	0.01%	563
2014 Q2	$229K	Hold	3,897	–	–	0.01%	575
2014 Q1	$226K	Sell	3,897 -650	-14%	-$34.8K	0.01%	563
2013 Q4	$243K	Hold	4,547	–	–	0.01%	557
2013 Q3	$281K	Hold	4,547	–	–	0.01%	532
2013 Q2	$276K	Buy	+4,547	New	+$271K	0.01%	499

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dai-ichi Life Holdings's DGX Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 2,716 shares — an estimated $230K sold.

Dai-ichi Life Holdings first reported a position in DGX in Q2 2013 and held it in 12 quarters. The position peaked at $299K in Q1 2015. 597 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

Dai-ichi Life Holdings reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
Dai-ichi Life Holdings sold 2,716 Quest Diagnostics shares in Q4 2016, an estimated $230K.
Dai-ichi Life Holdings first reported a position in Quest Diagnostics in Q2 2013 and held it in 12 quarters.
Dai-ichi Life Holdings's Quest Diagnostics position peaked at $299K in Q1 2015.
597 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.